
Chemicals & Petrochemicals
Valuation | |
|---|---|
| Market Cap | 7.95 kCr |
| Price/Earnings (Trailing) | 44 |
| Price/Sales (Trailing) | 5.07 |
| EV/EBITDA | 25.2 |
| Price/Free Cashflow | 45.77 |
| MarketCap/EBT | 32.85 |
| Enterprise Value | 7.92 kCr |
Fundamentals | |
|---|---|
Growth & Returns | |
|---|---|
| Price Change 1W | 0.20% |
| Price Change 1M | 0.20% |
| Price Change 6M | -24.7% |
| Price Change 1Y | -13.1% |
| 3Y Cumulative Return | -16.3% |
| 5Y Cumulative Return | -4.7% |
| 7Y Cumulative Return | 26% |
| 10Y Cumulative Return | 28.7% |
| Revenue (TTM) |
| 1.57 kCr |
| Rev. Growth (Yr) | -4.2% |
| Earnings (TTM) | 180.66 Cr |
| Earnings Growth (Yr) | -3.4% |
Profitability | |
|---|---|
| Operating Margin | 15% |
| EBT Margin | 15% |
| Return on Equity | 12.62% |
| Return on Assets | 10.31% |
| Free Cashflow Yield | 2.18% |
Cash Flow & Liquidity |
|---|
| Cash Flow from Investing (TTM) | -195.54 Cr |
| Cash Flow from Operations (TTM) | 263.1 Cr |
| Cash Flow from Financing (TTM) | -49.15 Cr |
| Cash & Equivalents | 24.85 Cr |
| Free Cash Flow (TTM) | 215.41 Cr |
| Free Cash Flow/Share (TTM) | 42.12 |
Balance Sheet | |
|---|---|
| Total Assets | 1.77 kCr |
| Total Liabilities | 323.83 Cr |
| Shareholder Equity | 1.44 kCr |
| Current Assets | 586.45 Cr |
| Current Liabilities | 184.71 Cr |
| Net PPE | 1.04 kCr |
| Inventory | 151.75 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.00 |
| Interest Coverage | 145.9 |
| Interest/Cashflow Ops | 158.54 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 10 |
| Dividend Yield | 0.64% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.10% |
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Size: Market Cap wise it is among the top 20% companies of india.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Profitability: Recent profitability of 12% is a good sign.
Past Returns: Underperforming stock! In past three years, the stock has provided -16.3% return compared to 12.8% by NIFTY 50.
Technicals: SharesGuru indicator is Bearish.
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Size: Market Cap wise it is among the top 20% companies of india.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Profitability: Recent profitability of 12% is a good sign.
Past Returns: Underperforming stock! In past three years, the stock has provided -16.3% return compared to 12.8% by NIFTY 50.
Technicals: SharesGuru indicator is Bearish.
Investor Care | |
|---|---|
| Dividend Yield | 0.64% |
| Dividend/Share (TTM) | 10 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 35.33 |
Financial Health | |
|---|---|
| Current Ratio | 3.17 |
| Debt/Equity | 0.00 |
Technical Indicators | |
|---|---|
| RSI (14d) | 41.79 |
| RSI (5d) | 49.49 |
| RSI (21d) | 50.26 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal |
Summary of Alkyl Amines Chemicals's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Management's outlook for Alkyl Amines Chemicals Limited indicates a cautious approach due to subdued demand in the first half of FY'26, attributed to geopolitical pressures and competitive dynamics. The volume growth has been only marginally up compared to last year, with expectations of a significantly lower year-on-year increase of around 5% instead of the typical 10%-15% growth. Methylamines have faced more substantial impacts than ethylamines, which remained relatively stable due to domestic market focus.
Key forward-looking points shared by management include:
Volume Projections: A subdued volume growth outlook for FY'26, confirming expectations of lower performance than previously anticipated.
New Product Launch: Expected mechanical completion for a new product in Kurkumbh by February-March 2026, with a total CAPEX of approximately Rs.120 crores. This product aims to cater to markets such as dyes and pigments and could serve as an import substitute.
Capacity and Utilization: The total saleable capacity projected is around 1.5 lakh tons, with plans for expansion dependent on market demands. Current utilization for ethylamines is about 60%-70%.
Acetonitrile Market Context: While recent anti-dumping duties have improved prices slightly, management noted uncertainty regarding long-term benefits due to aggressive pricing from Chinese competitors.
Geopolitical Impact: Exposure to US tariffs is approximately 1% of total sales, creating additional uncertainty but deemed manageable.
Overall, management emphasizes a hopeful return to a stable growth trajectory as global market conditions normalize, while they prepare to navigate existing challenges.
Understand Alkyl Amines Chemicals ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| YOGESH MATHRADAS KOTHARI | 57.62% |
| NIYOKO TRADING AND CONSULTANCY LLP | 3.83% |
| PURJEEKO TRADING & CONSULTANCY LLP | 3.81% |
| NINI YOGESH KOTHARI | 2.48% |
| SYK TRADING AND CONSULTANCY LLP | 1.54% |
| IKIGAI EMERGING EQUITY FUND | 1.54% |
| HEMENDRA MATHRADAS KOTHARI |
Detailed comparison of Alkyl Amines Chemicals against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| VINATIORGA | Vinati Organics | 15.87 kCr | 2.31 kCr | -5.20% | -13.60% | 35.83 | 6.87 | - | - |
| CLEAN | Clean Science and Technology | 9.15 kCr |
Comprehensive comparison against sector averages
ALKYLAMINE metrics compared to Chemicals
| Category | ALKYLAMINE | Chemicals |
|---|---|---|
| PE | 44.72 | 44.71 |
| PS | 5.15 | 4.17 |
| Growth | 0.1 % | 6.2 % |
Alkyl Amines Chemicals is a prominent player in the specialty chemicals sector, with the stock ticker ALKYLAMINE.
The company, which boasts a market capitalization of Rs. 9,153.3 Crores, specializes in the manufacture and supply of amines, amine derivatives, and other specialty chemicals, both in India and internationally.
Their product offerings include a wide range of aliphatic amine products such as:
Additionally, they produce various amine derivatives, including:
The company also provides specialty chemicals like acetonitrile and several other complex organic compounds. Alkyl Amines Chemicals serves diverse industries, including pharmaceuticals, agrochemicals, water treatment, and rubber chemicals.
Founded in 1979 and headquartered in Navi Mumbai, India, Alkyl Amines has shown resilience with a trailing 12 months revenue of Rs. 1,565.5 Crores.
The company not only focuses on growth—reporting a revenue increase of 3.6% over the past three years—but also delivers value to its investors by distributing a dividend yield of 1.14% per year. It's worth noting that the firm diluted its shareholder equity by 0.1% over the last three years, although it remains a profitable entity, with a profit of Rs. 178.5 Crores in the last four quarters.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
| Buy |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
ALKYLAMINE vs Chemicals (2021 - 2026)
Question: "Sir, last year, FY'25, we had seen a volume growth of close to around 13%. Just wanted to understand from you, what was the volume growth in this first half? And any indication of volume growth, which you can share for FY'26?"
Answer: "Nirav, the first half's volume growth has been marginally up from last year. However, we do not expect our normal 10%-15% growth this year due to various external factors. Therefore, volume growth will be subdued for FY'26."
Question: "Is the impact predominantly coming from the methylamines part, or is the ethylamines chain also impacted?"
Answer: "The impact is greater on methylamines than on ethylamines. Ethylamines remain largely domestically focused, thus minimizing competition and impact. However, while there is some effect on sales due to global demand changes, it's not as significant as with methylamines."
Question: "Sir, if you can also walk us through in terms of the current market size for methylamines and ethylamines in India?"
Answer: "The methylamine market is about 80,000 to 90,000 tons with a combined capacity exceeding 150,000 tons, affected by new entrants like Aarti Drugs. For ethylamines, the market size is estimated at 30,000 to 35,000 tons."
Question: "What is the CAPEX for the new product expected to launch by December?"
Answer: "The CAPEX is roughly Rs. 120 crores, with mechanical completion anticipated around February-March 2026. We expect commercialization in the first quarter of FY'26-27. This product mainly serves the dyes and pigments sector and is an import substitute."
Question: "Can you share your thoughts on acetonitrile and the impact of the anti-dumping duties?"
Answer: "Post-anti-dumping duties initiated in June, we experienced a spike in imports before those duties took effect. Prices improved slightly, but competitive pricing remains challenging due to aggressive Chinese pricing. We anticipate better market share and pricing moving forward."
Question: "What is the current capacity utilization for us in ethylamine?"
Answer: "Currently, we anticipate about 60%-70% capacity utilization for our ethylamine plant, commissioned 18 months ago, with substantial room for growth."
Question: "What is the direct export percentage to the US this H1 FY'26?"
Answer: "Our exposure to the US is about 4% of total exports, equating to possibly 1% of total sales. The mix includes various duty levels, complicating the overall impact of the US tariffs."
Question: "Is there a possibility of expanding capacities for acetonitrile in the future?"
Answer: "If demand warrants, we may consider capacity expansion, but decisions will depend on market growth and utilization rates. The last expansion was sizable, and any new investment will be carefully evaluated."
| 1.04% |
| SUNEET YOGESH KOTHARI | 0.75% |
| ANJYKO INVESTMENTS PVT LTD | 0.26% |
| KUNJLATA N SHAH | 0.15% |
| DEVANGANA JAYANT DESAI | 0.15% |
| SHUCHI HEMENDRA KOTHARI | 0.14% |
| ADITI KOTHARI DESAI | 0.14% |
| ANJALI Y KOTHARI | 0.12% |
Distribution across major stakeholders
Distribution across major institutional holders
| 1.01 kCr |
| -6.40% |
| -45.70% |
| 37.27 |
| 9.03 |
| - |
| - |
| SUDARSCHEM | Sudarshan Chemical Indus. | 7.2 kCr | 6.99 kCr | -5.40% | -10.80% | 42.83 | 1.03 | - | - |
| GALAXYSURF | Galaxy Surfactants | 6.48 kCr | 4.82 kCr | -8.10% | -25.00% | 22.64 | 1.35 | - | - |
| BALAMINES | Balaji Amines | 3.58 kCr | 1.41 kCr | +3.10% | -36.40% | 24.98 | 2.54 | - | - |
| -99.7% |
| 1.01 |
| 4.4 |
| 3.32 |
| 3.83 |
| 6.33 |
| 10 |
| Depreciation and Amortization | 20.7% | 71 | 59 | 45 | 35 | 29 | 27 |
| Other expenses | 3.4% | 338 | 327 | 382 | 293 | 197 | 182 |
| Total Expenses | 8% | 1,353 | 1,253 | 1,388 | 1,255 | 849 | 773 |
| Profit Before exceptional items and Tax | 23.4% | 249 | 202 | 309 | 302 | 401 | 227 |
| Exceptional items before tax | - | 0 | 0 | 0 | 0 | 0 | 33 |
| Total profit before tax | 23.4% | 249 | 202 | 309 | 302 | 401 | 260 |
| Current tax | 38.2% | 48 | 35 | 71 | 71 | 104 | 55 |
| Deferred tax | -17.6% | 15 | 18 | 8.79 | 5.79 | 1.21 | -10.3 |
| Total tax | 17% | 63 | 54 | 80 | 77 | 105 | 44 |
| Total profit (loss) for period | 25% | 186 | 149 | 229 | 225 | 295 | 215 |
| Other comp. income net of taxes | 3.7% | -1.37 | -1.46 | -1.87 | -0.35 | -2.38 | -1.3 |
| Total Comprehensive Income | 26% | 185 | 147 | 227 | 225 | 293 | 214 |
| Earnings Per Share, Basic | 25.9% | 36.4 | 29.125 | 44.75 | 44.043 | 57.872 | 42.22 |
| Earnings Per Share, Diluted | 25.5% | 36.25 | 29.088 | 44.68 | 43.951 | 57.72 | 42.108 |
| Debt equity ratio | - | 0 | - | - | - | 015 | - |
| Debt service coverage ratio | - | 2.5133 | - | - | - | 0.0231 | - |
| Interest service coverage ratio | - | 2.4747 | - | - | - | - | - |